Coleen McNamara

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development.

Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.

Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation.

Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation.

Phosphorylation regulates Id3 function in vascular smooth muscle cells.

Id family of transcription factors and vascular lesion formation.

The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.

Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.

Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3.

Are thiazolidinediones good or bad for the heart?

Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus.

The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectin.

Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis.

Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans.

Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury.

Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease.

B-cell aortic homing and atheroprotection depend on Id3.

Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.

Lymphocytes and the adventitial immune response in atherosclerosis.

Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis.

Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice.

B cell subsets in atherosclerosis.

Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.

Understanding the role of B cells in atherosclerosis: potential clinical implications.

Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.

A functionally significant polymorphism in ID3 is associated with human coronary pathology.

Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

B2 cells suppress experimental abdominal aortic aneurysms.

B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.

Pannexin 1 is required for full activation of insulin-stimulated glucose uptake in adipocytes.

Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue.

Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.

Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.

Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis.

B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.

Corrigendum to "Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays" [Thromb. Res. 139 (2016) 90-97].

Regulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.

B cells and atherosclerosis.

Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.

Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis.

Perivascular Adipose Tissue Harbors Atheroprotective IgM-Producing B Cells.

Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.

Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis.

IgE to the Mammalian Oligosaccharide Galactose-α-1,3-Galactose Is Associated With Increased Atheroma Volume and Plaques With Unstable Characteristics-Brief Report.

A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.

Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry.

IgE, α-Gal and atherosclerosis.

c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells.

Cell- and Sex-Specific Role of FcγR (Fcγ Receptor) IIb in Experimental Atherosclerosis.

Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.

Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.

Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed Mice.

Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects.

2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.

liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects.

B Lymphocytes and Adipose Tissue Inflammation.

PPARγ and PPARα synergize to induce robust browning of white fat in vivo.